A drug which is said to "reboot" the immune system has been shown to be an effective treatment for multiple sclerosis (MS), a study has found.
The results of the trials were so encouraging in reducing the number of attacks in those affected that the MS Society is campaigning for the drug to become available on the NHS.
The research showed that alemtuzumab significantly reduced the number of attacks or relapses by people with MS compared to the current drug interferon beta-1a which is known commercially as Rebif.
More top news
Researchers found taking the drugs was associated with a 36% heightened risk of being diagnosed with type 2 diabetes.
The study reveals cases of slave driving and human trafficking suffering delays, being prematurely shelved or being overlooked entirely.
David Clarke was arrested after a four-hour standoff in which two members of staff were taken hostage. Both escaped unharmed.